MDxHealth (MDXH) Total Non-Current Liabilities (2020 - 2026)
MDxHealth (MDXH) posted Total Non-Current Liabilities of $139.5 million for Q1 2026, up 26.21% sequentially from $110.5 million in Q4 2025, and up 10.96% YoY from $125.7 million in Q1 2025.
MDxHealth (MDXH) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
MDxHealth has reported Total Non-Current Liabilities for 7 years, with the latest figure at $139.5 million in Q1 2026.
- Quarterly Total Non-Current Liabilities rose 10.96% year-over-year to $139.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $139.5 million (up 10.96% YoY) and the FY2025 annual result came in at $110.5 million, up 10.71% from the prior year.
- Total Non-Current Liabilities climbed to $139.5 million in Q1 2026 per MDXH's latest filing, from $110.5 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $112.0 billion in Q2 2025 and troughed at $74.5 million in Q2 2023.
- A 5-year average of $7.6 billion and a median of $99.8 million in 2024 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2023 and 2025: Total Non-Current Liabilities fell 9.17% in 2023, then soared 118218.58% in 2025.
- Over 5 years, Total Non-Current Liabilities stood at $91.5 million in 2022, then rose by 11.86% to $102.4 million in 2023, then fell by 2.52% to $99.8 million in 2024, then advanced by 10.71% to $110.5 million in 2025, then grew by 26.21% to $139.5 million in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $139.5 million, $110.5 million, and $111.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 108.64 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 85.84 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 715.49 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 5.45 Bn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 22.94 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 542.10 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 6.36 Bn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 3.39 Bn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 9.19 Bn |
| 10 | MDxHealth | 36.03 Mn | 15.62 Mn | 17.89 Mn | 125.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 125.09 Mn |
| Mar 31, 2026 | 139.48 Mn |
| Dec 31, 2025 | 110.51 Mn |
| Sep 30, 2025 | 111.38 Mn |
| Jun 30, 2025 | 112.00 Bn |
| Mar 31, 2025 | 125.71 Mn |
| Dec 31, 2024 | 65.28 Mn |
| Sep 30, 2024 | 94.87 Mn |
| Jun 30, 2024 | 94.66 Mn |
| Mar 31, 2024 | 103.77 Mn |
| Dec 31, 2023 | 66.66 Mn |
| Sep 30, 2023 | 99.04 Mn |
| Jun 30, 2023 | 74.52 Mn |
| Dec 31, 2022 | 60.15 Mn |
| Sep 30, 2022 | 81.82 Mn |
| Jun 30, 2022 | 82.05 Mn |
| Dec 31, 2021 | 8.55 Mn |
| Dec 31, 2020 | 9.49 Mn |